NURS FPX 8004 Assessment 4 Literature Review

NURS FPX 8004 Assessment 4

Literature Review

Order ready-to-submit essays - 100% plagiarism-free guaranteed!

Note: Our papers are 100% human-written. 

Student name

Capella University

NURS-FPX8004

Professor Name

Submission Date

Introduction

The existing deficiencies in monitoring and follow-up of pulmonary hypertension guided by the guidelines required the formulation of the PICOT question as follows: In patients aged 12-75 years with pulmonary hypertension (P), how does the implementation of a standardized and evidence-based monitoring protocol (I), in comparison to current practices (C) impact adherence rate to treatment protocol (O) in 12 months (T)? A methodical search of English-language and peer-reviewed literature between 2020 and 2025 was implemented using databases in PubMed, the Cumulative Index of Nursing and Allied Health Literature (CINAHL) Complete, Scopus, and MEDLINE. The main search words were pulmonary hypertension, follow-up, monitoring protocol, guideline adherence and hospital admissions. The search resulted in 163 records; the relevance filters of outpatient focus, clear monitoring intervention and hospitalization or adherence outcome decreased the list of articles to 14 high-quality articles. Collectively, the studies demonstrate how the formalized monitoring, packaged clinic visits to telemetry physiologic monitoring, relentlessly enhances monitoring compliance, detects clinical deterioration sooner, and decreases emergency utilization, affirming the significance of active, protocol-directed monitoring in pulmonary-hypertension management.

Thematic Synthesis of Literature

Theme 1: Protocol-Driven Follow-up and Monitoring Improves Guideline Adherence

It is shown that structured follow-up plans drive stronger compliance with pulmonary-hypertension (PH) recommendations and the faster escalation to optimal treatment. McLaughlin et al. (2022) paid attention to a multicentre quality-improvement programme of pulmonary arterial hypertension (PAH). The program combined algorithm-based visits and decision aids; more than 95 percent of functional-class II/III patients received combination of drugs to the guideline following 36 months; the compliance was 28.6 percent when the external factors could not prevent patients to accept parenteral therapy, which is the impact of the protocol on clinician behavior without any external forces. Wigger et al. (2020) reported provider-centered interventions also enhanced compliance in systemic-sclerosis clinics: baseline screening involving annual echocardiography and pulmonary-function testing was 69.2%, yet specific education alongside an electronic best-practice notification raised monthly compliance by 10.4, or a modest 10.4, which revealed compliance gaps and ordering friction as modifiable barriers. A treatment-pathway analysis by Chin et al. (2024) showed that contemporary four-drug, pathway-specific regimens and timely referral to lung-transplant care depends heavily on regular, bundled haemodynamics, functional-class, and imaging assessment, with scrupulous monitoring directly proportional to improved haemodynamics, exercise capacity, and survival. Collectively, the articles demonstrate that protocols, whether in the form of electronic reminders, visit protocols, or algorithmic treatment pathways are essential to the translation of guidelines into consistent, high-quality PH care.

Theme 2: Digital Health and Remote Monitoring Feasibility

It has been shown that tele-enabled testing and eHealth systems have the capacity to enhance guideline-based surveillance in pulmonary hypertension (PH) beyond the clinic. Different at-home exercise tests were also tested in the PHRET trial by Stubbs et al. (2023), which reported high correlations between tele-6-minute-walk distance (r=0.93) and the conventional corridor testing with at least 92 percent of participants supporting continued home testing; only half of the participants were able to complete the GPS-based walk, but nearly all could complete easier sit-to-stand or timed-up-and-go tests, supporting feasibility across different functional levels. The literature review of Garcia et al. (2020) supports the findings. There were 18 pilot studies in the broader context of eHealth in PAH, including implantable pulmonary artery pressure sensors to smartphone walk-test applications. Although the samples were small, two trials linked remote hemodynamic or activity monitoring to reduced hospitalization, suggesting clinical potential that should be the subject of large-scale trials.

Telehealth has been found useful in pulmonary hypertension and the viability of the practice should be researched. McCormack et al. (2024) discovered that when the device-centered reports, a 10-week, theory-based home-exercise program was offered by video, mobile messaging, and health-coaching it was a safe (no adverse events), acceptable, and led to significant improvements in functional capacity, everyday activity, self-efficacy, and quality of life. In a similar way, the qualitative questionnaires applied by Stubbs et al. (2022) also revealed high patient willingness to transmit electronic symptom and quality-of-life questionnaires, which supports user readiness to digital follow-up. Combined, the literature demonstrates the technical feasibility, acceptability, and capability of remote exercise testing, tele-coaching, and sensor-based physiologic monitoring to generate clinically valuable information, paving the way to protocol-based, at-home follow-up models that can improve access and adherence in PH practice.

Theme 3: Clinical Predictors and Risk Stratification

The recent literature has reached a consensus to use more detailed, and preferably continuous, clinical information to refine risk-prediction tools. Sonnweber et al. (2021) performed a large retrospective cohort study comparing seven models recommended by the guidelines and confirmed that most scores are predictive of low-risk precapillary PH but not of intermediate- and high-risk. The addition of simple non-invasive markers, age of patient and area of right-atrium significantly improved mortality prediction, and this identifies weaknesses in current abbreviated calculators. The potential of telehealth was highlighted by parallel work by Milks et al. (2021) during the time of COVID -19. Experts reviewers described the ability of remote functional testing, home hemodynamics, and wearable sensors to assist in objective reassessment of risk during the interval between in-person visits but advocated testing to prepandemic standards. 

Heart rate variability is a clinical indicator that is helpful in pulmonary hypertension patients. In a prospective trial, Andersen et al. (2023) tested implantable loop recorders and demonstrated that the continuously measured heart-rate variability and activity indices were highly correlated with ESC/ERS risk scores and were independent predictors of 1-year mortality, confirming that dynamic physiologic monitoring can improve prognostication over and above static clinic snapshots. Collectively, the articles show that incorporating age, right-atrial dimension, and real-time wearable measurements into the existing algorithms can address accuracy gaps, particularly when a patient has an unknown risk status, allowing an earlier therapy to be modified and more personalized pulmonary-hypertension management.

Recommendations for Future Research and Practice

Future studies should combine multi-center, randomized trials of regimented follow-up packages with stringent cost-utility analysis to determine that intended functional testing, biomarker panels, and decision-support notifications are truly effective in improving outcomes and decreasing costs. At the same time, investigators must also validate tele-6-minute-walks, wearable heart-rate- variability streams, and other remote measures against gold-standard hemodynamics to be able to incorporate the data into dynamic calculators of risk (Garcia et al., 2020). Hybrid telehealth/clinic pathways should be assessed in mixed populations (geographically and socio-economically) to identify effects on equity, therapy escalation, and patient experience, and behavioral science research order-set reminders, shared-decision supports, and coaching to overcome residual provider or patient resistance to guideline therapy. On a clinical level, programs can intervene by inserting algorithm-based reminders into the electronic health records (EHR), introducing a 6-month surveillance protocol that includes functional class review, NT- proBNP, imaging, and a validated remote exercise test, and supplementing the current risk scores with simple non-invasive markers, such as age and right-atrial area (Chin et al., 2024). Multidisciplinary training of the protocols and realistic use of the distant devices needs to be widespread in order to achieve at least 90 percent compliance and to be able to turn digital innovations into timely escalation, shorter hospitalization, and eventually increased survival among patients with pulmonary hypertension.

Conclusion

The review summarized emerging data that demonstrate that structured follow-up pathways, evaluated tele-monitoring systems, and greater use of risk-stratification models all enhance guideline adherence and patient outcome in pulmonary hypertension. These findings can be incorporated into the project to introduce an evidence-based monitoring protocol that would be backed by digital health and ongoing risk assessment. The methodology seeks to eliminate care disparities and inform research directions to scalable and fair treatment of pulmonary hypertension.